Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 16.58
(-0.66%)
CNY 16.58
(-0.66%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.07 Billion CNY | 11.31% |
| 2022 | 1.8 Billion CNY | 41.59% |
| 2021 | 1.27 Billion CNY | 74.53% |
| 2020 | 732.13 Million CNY | 17.42% |
| 2019 | 623.51 Million CNY | 30.53% |
| 2018 | 477.69 Million CNY | 72.08% |
| 2017 | 277.6 Million CNY | 43.6% |
| 2016 | 193.31 Million CNY | 28.72% |
| 2015 | 150.17 Million CNY | 8.45% |
| 2014 | 138.47 Million CNY | 4.34% |
| 2013 | 132.71 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 422.37 Million CNY | -27.61% |
| 2024 Q2 | 553.72 Million CNY | 31.1% |
| 2024 Q3 | 583.57 Million CNY | 5.39% |
| 2023 FY | 2.01 Billion CNY | 11.31% |
| 2023 Q2 | 570.69 Million CNY | 51.81% |
| 2023 Q1 | 375.93 Million CNY | -32.54% |
| 2023 Q3 | 529.69 Million CNY | -7.19% |
| 2023 Q4 | 583.47 Million CNY | 10.15% |
| 2022 Q2 | 449.42 Million CNY | 26.53% |
| 2022 Q3 | 447.35 Million CNY | -0.46% |
| 2022 FY | 1.8 Billion CNY | 41.59% |
| 2022 Q4 | 557.24 Million CNY | 24.56% |
| 2022 Q1 | 355.2 Million CNY | -7.67% |
| 2021 Q1 | 215.31 Million CNY | -9.89% |
| 2021 FY | 1.27 Billion CNY | 74.53% |
| 2021 Q4 | 384.7 Million CNY | 21.47% |
| 2021 Q3 | 316.71 Million CNY | -12.27% |
| 2021 Q2 | 361.02 Million CNY | 67.67% |
| 2020 Q3 | 203.31 Million CNY | 13.11% |
| 2020 Q2 | 179.75 Million CNY | 63.26% |
| 2020 FY | 732.13 Million CNY | 17.42% |
| 2020 Q1 | 110.1 Million CNY | -41.48% |
| 2020 Q4 | 238.95 Million CNY | 17.53% |
| 2019 Q2 | 159.39 Million CNY | 41.66% |
| 2019 FY | 623.51 Million CNY | 30.53% |
| 2019 Q1 | 112.51 Million CNY | -23.47% |
| 2019 Q3 | 163.45 Million CNY | 2.55% |
| 2019 Q4 | 188.14 Million CNY | 15.11% |
| 2018 Q1 | 95.58 Million CNY | -9.21% |
| 2018 FY | 477.69 Million CNY | 72.08% |
| 2018 Q4 | 147.02 Million CNY | 19.28% |
| 2018 Q3 | 123.26 Million CNY | 10.23% |
| 2018 Q2 | 111.82 Million CNY | 16.99% |
| 2017 Q4 | 105.27 Million CNY | 57.58% |
| 2017 FY | 277.6 Million CNY | 43.6% |
| 2017 Q3 | 66.81 Million CNY | 7.82% |
| 2017 Q2 | 61.96 Million CNY | 42.32% |
| 2017 Q1 | 43.54 Million CNY | -32.03% |
| 2016 Q4 | 64.06 Million CNY | 33.18% |
| 2016 Q3 | 48.1 Million CNY | 18.56% |
| 2016 Q2 | 40.57 Million CNY | 29.16% |
| 2016 Q1 | 31.41 Million CNY | -23.02% |
| 2016 FY | 193.31 Million CNY | 28.72% |
| 2015 Q1 | 34.28 Million CNY | -7.49% |
| 2015 Q4 | 40.8 Million CNY | 0.0% |
| 2015 FY | 150.17 Million CNY | 8.45% |
| 2015 Q3 | 40.8 Million CNY | 19.03% |
| 2015 Q2 | 34.28 Million CNY | 0.0% |
| 2014 Q3 | 37.47 Million CNY | 18.01% |
| 2014 Q1 | 31.75 Million CNY | 0.0% |
| 2014 FY | 138.47 Million CNY | 4.34% |
| 2014 Q2 | 31.75 Million CNY | 0.0% |
| 2014 Q4 | 37.05 Million CNY | -1.12% |
| 2013 FY | 132.71 Million CNY | 0.0% |